Physician profile
Christy E Lee
NPI 1932406832
$2,459.54
in general payments reported to CMS, 2019-2025
13 companies · $994 in 2025
The $994 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.43 · 2022: $196 · 2023: $481 · 2024: $710 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $904.40 | 2021-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $537.92 | 2023-2025 | Entyvio |
| Abbvie INC. | $179.49 | 2023-2025 | |
| Novo Nordisk INC | $165.54 | 2024-2025 | Wegovy |
| Viatris Specialty LLC | $122.10 | 2025 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $121.12 | 2023 | Dupixent |
| Edwards Lifesciences Corporation | $95.60 | 2025 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $95.05 | 2024 | Airsupra |
| Sage Therapeutics, LLC | $79.75 | 2024 | |
| Neurelis, INC. | $59.26 | 2025 | Valtoco |
| Kyowa Kirin, INC. | $51.60 | 2025 | |
| Evoke Pharma, INC. | $32.79 | 2021 | |
| Janssen Biotech, INC. | $14.92 | 2025 | Simponi Aria, Stelara, Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.